Article

Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment

2025-07-21

Abstract excerpt

<h4>Background: </h4> /Objectives: The advent of kinase inhibitors (TKI), therapeutic antibodies and inducers of apoptosis has revolutionized cancer treatment, yet their application in pediatric tumors, particularly medulloblastoma, remains understudied. Understanding the expression of these targets in specific genetic subgroups could unveil potential repositioning opportunities for already approved drugs. <h4>Met...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 17ba477b-0896-5948-b8e2-1b705938a4c3
DOI: 10.20944/preprints202507.1627.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma TreatmentDOI 10.20944/preprints202507.1627.v1Read

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.Semantic proximity Read

Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma.Semantic proximity Read

Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a TimeSemantic proximity Read

Emerging treatments and gene expression profiling in high-risk medulloblastoma.Semantic proximity Read

New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.Semantic proximity Read

“The anti-angiogenic compound axitinib demonstrates low toxicity and anti-tumoral effects against medulloblastoma”Semantic proximity Read

The Medulloblastoma Meta-Analysis Portal Enables Integrative Exploration of Clinical and Genomic Data from Patients.Semantic proximity Read

The impact of molecularly matched treatment and tumor mutational burden on pediatric brain tumor patient outcomesSemantic proximity Read

Cell Model Representatives of Pediatric Neuroblastoma: Evidence from Transcriptomic Ranking and Pharmacogenomic Connectivity AnalysisSemantic proximity Read

Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trialSemantic proximity Read

Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.Semantic proximity Read

In silico drug sensitivity predicts subgroup-specific therapeutics in medulloblastoma patientsSemantic proximity Read